CVS Health Corporation (SNSE:CVS)

Chile flag Chile · Delayed Price · Currency is CLP · Price in USD
78.63
0.00 (0.00%)
At close: Mar 9, 2026
Market Cap86.43T +14.7%
Revenue (ttm)360.16T +7.9%
Net Income1.59T -61.7%
EPS1,252.07 -62.0%
Shares Outn/a
PE Ratio54.27
Forward PE10.57
Dividend2,468.79 (3,139.75%)
Ex-Dividend DateJan 22, 2026
Volumen/a
Average Volumen/a
Openn/a
Previous Close78.63
Day's Rangen/a
52-Week Range49.82 - 80.50
Betan/a
RSI100.00
Earnings DateApr 29, 2026

About CVS Health

CVS Health Corporation provides health solutions in the United States. The company operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, medical management capabilities, Medicare Advantage and Medicare Supplement plans, PDPS and Medicaid health care management services. It serves employer groups, individu... [Read more]

Industry Health Services
Founded 1963
Employees 259,500
Stock Exchange Santiago Stock Exchange
Ticker Symbol CVS
Full Company Profile

Financial Performance

In 2025, CVS Health's revenue was $399.83 billion, an increase of 7.87% compared to the previous year's $370.66 billion. Earnings were $1.77 billion, a decrease of -61.68%.

Financial numbers in USD Financial Statements

News

CVS Health Foundation Invests $2.24 Million to Expand Community‑Based Care Through Health Impact Ohio

Health Zones effort aims to improve health care access, reduce emergency utilization and support residents with chronic conditions COLUMBUS, Ohio, March 10, 2026 /PRNewswire/ --The CVS Health Foundati...

9 hours ago - PRNewsWire

CVS Health Corporation (CVS) Presents at Leerink Global Healthcare Conference 2026 Transcript

CVS Health Corporation (CVS) Presents at Leerink Global Healthcare Conference 2026 Transcript

1 day ago - Seeking Alpha

CVS Health: Stop Catastrophizing, Start Believing - Here's Why

CVS Health Corporation is rated a Buy, with a bullish outlook for 2026–2027 driven by margin recovery and undervalued valuation metrics. CVS trades at attractive forward P/S (~0.25x) and P/E (~13x), w...

4 days ago - Seeking Alpha

CVS Health And Google Launch AI Business To ‘Personalize Healthcare'

CVS Health and Google have partnered to use artificial intelligence and related cloud-based technology to increase consumer and patient engagement, and "ultimately support better health outcomes,” the...

5 days ago - Forbes

CVS taps Google Cloud to roll out AI-powered health platform

CVS Health will launch an AI-enabled platform in partnership with Alphabet's Google Cloud unit that will ​bring together data from diverse sources to help ‌customers manage their health in real time, ...

5 days ago - Reuters

CVS Health and Google Cloud announce new strategic partnership to reimagine healthcare consumer engagement and experiences

Health100, a health technology services subsidiary of CVS Health will launch a new first-of-its-kind AI-native consumer engagement platform to be the destination of choice for a connected, proactive, ...

5 days ago - PRNewsWire

CVS Health Announces $5 Million Scholarship Program to Support Future Pharmacists in Louisiana

Investment aims to strengthen the pharmacy workforce and expand access to care across the state BATON ROUGE, La., Feb. 18, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced the launch of a ...

20 days ago - PRNewsWire

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...

21 days ago - Benzinga

Saggio Realty Announces Milestone Linked to Sale of Marco Island's CVS-Anchored Plaza

Mike Rivera Of Naples Fl Congratulates Hendricks Commercial Properties on Exceptional Return From Sale of Marco Island's CVS-Anchored Island Plaza Mike Rivera Of Naples Fl Congratulates Hendricks Comm...

24 days ago - GlobeNewsWire

These 32 favorite stocks signal the bull market is running on fumes

The S&P 500 sectors that top investment newsletters currently like most are strongest at market peaks.

26 days ago - Market Watch

Analysts See Multiple Growth Levers For CVS Health In 2026

CVS Health Corp. (NYSE: CVS) reported sales of $105.69 billion, beating the consensus of $103.59 billion on Tuesday.

27 days ago - Benzinga

CVS Health: Why Margin Compression In Aetna Limits The Upside For 2026

CVS Health Corporation is rated a Hold, reflecting balanced risk and income potential amid persistent Medicare Advantage cost pressures. Q4 2025 saw record revenue, but rising medical costs in Aetna d...

4 weeks ago - Seeking Alpha

CVS Health Corporation (CVS) Q4 2025 Earnings Call Transcript

CVS Health Corporation (CVS) Q4 2025 Earnings Call Transcript

4 weeks ago - Seeking Alpha

CVS Health beats expectations as turnaround strategy gains traction

CVS Health delivered a stronger-than-expected fourth quarter, beating Wall Street estimates on both earnings and revenue as the company presses ahead with a multi-year turnaround. The results underlin...

4 weeks ago - Invezz

CVS Profits Hit Nearly $3 Billion As Aetna's Costs Slowly Stabilize

CVS Health Tuesday reported $2.9 billion in fourth quarter net income as the company slowly begins to get a handle on costs that have hit its Aetna health insurance business hard.

4 weeks ago - Forbes

CVS Stock Falls After Earnings Beat. Why Medicare Worries Persist.

CVS Health earnings came in ahead of analyst forecasts but the company is concerned about Medicare rates.

4 weeks ago - Barrons

CVS Health's turnaround is paying off amid widespread changes to health insurance and retail pharmacy businesses

The healthcare giant saw its revenue jump 8% in the fourth quarter

4 weeks ago - Market Watch

CVS Profit, Revenue Climb as Turmoil Continues in Health-Insurance Sector

CVS Health reported earnings that beat analysts' expectations and kept its 2026 profit guidance unchanged, results that may soothe investors spooked by continued turmoil in the health-insurance sector...

4 weeks ago - WSJ

CVS Health beats quarterly profit expectations on pharmacy performance

CVS Health reported a decline in fourth-quarter profit on Tuesday but beat Wall Street estimates, helped by strength in its pharmacy benefit unit and strong prescription volume at its retail pharmacie...

4 weeks ago - Reuters

CVS tops quarterly estimates, reaffirms profit outlook as turnaround plan takes effect

CVS Health reported fourth-quarter earnings and revenue that beat estimates and reaffirmed the 2026 profit guidance that previously impressed investors. The results signal steady progress in the healt...

4 weeks ago - CNBC

CVS HEALTH CORPORATION REPORTS FOURTH QUARTER AND FULL-YEAR 2025 RESULTS

Fourth Quarter Highlights Total revenues increased to $105.7 billion, up 8.2% compared to prior year GAAP diluted EPS of $2.30 and Adjusted EPS of $1.09 Full-Year Highlights Total revenues increased t...

4 weeks ago - PRNewsWire

Jobs, Consumer Prices, Coca-Cola, CVS, Ford, McDonald's, and More to Watch This Week

The Federal Reserve's dual mandate will be covered this week with the release of the January jobs report and the consumer price index. Plus, earnings from Cisco Systems, Applied Materials, Arista, and...

4 weeks ago - Barrons

CVS Pharmacy Now Accepting TrumpRx Discount Cards

WOONSOCKET, R.I., Feb. 6, 2026 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that its approximately 9,000 community pharmacies are accepting TrumpRx discount cards, which offer savings on ce...

4 weeks ago - PRNewsWire

Aetna, a CVS Health company, receives Health Plan of the Year Award from Press Ganey

Press Ganey's inaugural Health Plan of the Year award recognizes Aetna's sustained excellence across member experience, quality performance and provider collaboration. HARTFORD, Conn.

4 weeks ago - PRNewsWire

CVS Health to drop Amgen and Lilly's bone disease treatments from some drug lists

CVS Health said on Thursday it would swap out Amgen and Eli Lilly's bone disease treatments for lower-cost alternatives in some of its preferred drug lists, starting April 1.

4 weeks ago - Reuters